Cell therapies directed at the damaged ventricle hold promise for improving ventricular function but with potential proarrhythmic electrophysiological effects. Fukushima and colleagues assessed the effects of bone marrow-derived stem cells administered by direct intraventricular injection or retrogradely via injection into the coronary venous system 3 weeks after myocardial infarction in rats. The 2 routes of delivery produced similarly small amounts of donor cells persisting in the myocardium and a similar improvement in LV ejection fraction. ECG telemetry revealed spontaneous ventricular arrhythmias that were prominent for the first 2 weeks after intramyocardial injection but not after intracoronary injection. Further examination showed inflammatory cell clusters after intramyocardial injection but not after intracoronary injection. Thus, the route of delivery influenced short-term arrhythmias independent of the effect on ventricular function. The findings emphasize the potential importance of the route of delivery as a determinant of adverse effects that will need to be considered in human trials. See p 2254.
RANDOMIZED TRIAL COMPARING SAME-DAY DISCHARGE WITH OVERNIGHT HOSPITAL STAY AFTER PERCUTANEOUS CORONARY INTERVENTION: RESULTS OF THE ELECTIVE PCI IN OUTPATIENT STUDY (EPOS), by Heyde et al.
Patients who undergo percutaneous coronary interventions in the United States are routinely hospitalized overnight for observation to facilitate monitoring for the occurrence of any major complications. With improvements in the procedure, particularly the widespread use of stents, the likelihood of complications has fallen dramatically. The discharge of a patient who has had a successful procedure and is stable would improve patient satisfaction and reduce procedure-related costs. The study reported by Heyde et al in this issue of Circulation was a randomized trial of same-day discharge or overnight stay in 800 consecutive patients scheduled for elective angioplasty. Patients were then evaluated after the procedure as to whether they met predefined criteria for same-day randomization. Twenty percent of both groups did not. The primary outcome of death, myocardial infarction, coronary artery bypass graft surgery, repeat percutaneous coronary intervention, or puncture-related complications within 24 hours of percutaneous coronary intervention was not different between groups (2.2% for same-day and 4.2% for the overnight group). The findings were similar at 30 days. The study by Heyde et al confirms that selected patients undergoing elective percutaneous coronary intervention and who have had a successful procedure without complications can be safely discharged the same day. The implications for savings of healthcare costs are significant. See p 2299.
TARGETING PLATELETS IN ACUTE EXPERIMENTAL STROKE: IMPACT OF GLYCOPROTEIN IB, VI, AND IIB/IIIA BLOCKADE ON INFARCT SIZE, FUNCTIONAL OUTCOME, AND INTRACRANIAL BLEEDING, by Kleinschnitz et al.
Platelet adherence to the vessel wall is mediated by select surface glycoproteins and is often the first phase in the formation of a thrombus. Although much is known about this process in the coronary arteries, less is known about the relative role of select platelet glycoproteins in the cerebral circulation and stroke. In the current issue of Circulation, Kleinschnitz and colleagues study antibodies against platelet glycoproteins that mediate vessel wall adhesion in an animal stroke model. They report that blocking platelet adhesion decreased the degree of stroke. In addition, blocking platelet adhesion was not accompanied by the increased cerebral hemorrhage that was seen with use of a glycoprotein IIb/IIIa inhibitor. These results suggest that inhibition of platelet adhesion to the vessel wall could be a viable treatment for ischemic stroke and suggest the utility of further clinical investigation. See p 2323. 
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